BlueRock Therapeutics logo

Director, Pharmacovigilance Scientist

BlueRock Therapeutics

Cambridge, MAHybridPosted 2 days ago$204,000.00 - $216,000.00 per year
Full TimeDirector & AbovePharmacovigilance / Drug SafetyBiotechnology
Original posting ↗

Summary

The Director, Pharmacovigilance Scientist, will lead pharmacovigilance activities for assigned development programs, providing both strategic and operational safety leadership. Focused on both neurology and ophthalmology therapeutic areas, this role will remain therapeutically flexible to meet organizational needs. The Director will act as the dedicated PV lead for assigned programs, partnering with Clinical Development MDs, Safety Physicians, Regulatory Affairs, Clinical Operations, and other cross-functional teams including interfacing with safety teams in the parent company, to ensure comprehensive oversight of safety deliverables, regulatory compliance, risk management, and inspection readiness.

Job description

Responsibilities

  • Serve as the PV lead for assigned programs, accountable for end-to-end safety deliverables including proactive signal detection, validation, evaluation, and tracking of emerging safety signals from clinical data sources; author signal evaluation reports; plan, author, and scientifically review aggregate safety reports; and lead development of risk management plans.
  • Oversee the medical review of SAEs and ensure medically accurate narratives and consistent MedDRA coding.
  • Facilitate internal Safety Management Teams (SMTs), and support Data Monitoring Committees (DMCs) by analyzing and evaluating safety data and presenting findings.
  • Lead the preparation and PV input into core clinical trial documents, including study protocols, Investigator's Brochures, ICFs, SAPs, CRFs, CSRs, author safety summaries for Health Authority submissions (including responses to safety inquiries) and regulatory filings, and labeling documents for assigned programs.
  • Develop and maintain program-level PV strategies aligned with global regulatory requirements and company objectives.
  • Lead PV contributions to regulatory authority interactions and audit and inspection readiness activities for assigned programs, ensuring compliance of safety documentation and SOPs with ICH guidelines and GVP.
  • Partner with and oversee CROs and vendors handling case processing and manage SDEAs to ensure timely and compliant PV deliverables; monitor and track performance, and escalate issues as needed.
  • Contribute to departmental process improvement and knowledge-sharing initiatives.
  • Mentor junior staff or consultants supporting PV deliverables, and drive continuous improvement in PV systems.

Minimum Requirements

  • Advanced clinical or scientific degree in Pharmacy, Nursing, Epidemiology, Biosciences, or related healthcare discipline (PharmD, PhD, RN/MSN, or MD non-practicing/industry track).
  • 10+ years of progressive in drug safety and pharmacovigilance within the pharmaceutical or biotechnology industry.
  • Extensive, demonstrated, hands-on experience managing clinical trial safety (phases I-III) as the PV lead for global clinical programs across multiple phases.
  • Strong, direct expertise in safety data evaluation, signal detection, signal evaluation, benefit-risk assessments, authoring and reviewing major clinical safety documents (IBs, RSI, protocols), aggregate reporting (DSURs), and regulatory submissions.
  • Deep command of global PV regulations and guidelines, specifically FDA (21 CFR 312.32), EMA, and ICH guidelines for investigational products and Advanced Therapy Medicinal Products (ATMPs).
  • Mastery of standard safety databases (e.g., Argus, Veeva Vault Safety) and medical coding dictionaries to execute complex search strategies.
  • Proven ability to represent PV in cross-functional and external regulatory settings.
  • Experience collaborating with and influencing senior cross-functional stakeholders in a matrix environment.
  • Excellent communication, organizational, and leadership skills.
  • Ability to manage competing priorities in a fast-paced, dynamic environment.

Desirable Skills Preferred

  • Experience in biologics Cell Therapy (e.g., iPSC, CAR-T) or Gene Therapy, and in long-term follow-up protocols, ability to distinguish between procedure-related vs. product-related AEs.
  • Direct experience in neurology (especially neurodegenerative disorders) and/or ophthalmology (such as retinal diseases).

Requirements

  • Advanced clinical or scientific degree in Pharmacy, Nursing, Epidemiology, Biosciences, or related healthcare discipline (PharmD, PhD, RN/MSN, or MD non-practicing/industry track)
  • 10+ years of progressive experience in drug safety and pharmacovigilance within the pharmaceutical or biotechnology industry
  • Extensive, demonstrated, hands-on experience managing clinical trial safety (phases I-III) as the PV lead for global clinical programs across multiple phases
  • Strong, direct expertise in safety data evaluation, signal detection, signal evaluation, benefit-risk assessments, authoring and reviewing major clinical safety documents (IBs, RSI, protocols), aggregate reporting (DSURs), and regulatory submissions
  • Deep command of global PV regulations and guidelines, specifically FDA (21 CFR 312.32), EMA, and ICH guidelines for investigational products and Advanced Therapy Medicinal Products (ATMPs)
  • Mastery of standard safety databases (e.g., Argus, Veeva Vault Safety) and medical coding dictionaries to execute complex search strategies
  • Proven ability to represent PV in cross-functional and external regulatory settings
  • Experience collaborating with and influencing senior cross-functional stakeholders in a matrix environment
  • Excellent communication, organizational, and leadership skills
  • Ability to manage competing priorities in a fast-paced, dynamic environment

Benefits

  • Estimated compensation range $204,000 - $216,000 per year
  • Equal opportunity workplace
  • Disability-related accommodation available

Company overview

BlueRock Therapeutics is a clinical-stage biotechnology company pioneering engineered cell therapies for the treatment of devastating neurological and ophthalmic diseases. Founded in 2016 as a joint venture between Versant Ventures and Leaps by Bayer, the company became a wholly owned, independently operated subsidiary of Bayer AG in late 2019. BlueRock leverages its proprietary induced pluripotent stem cell (iPSC) platform to develop novel cellular medicines that aim to transform disease treatment through regenerative approaches. The company's pipeline includes two clinical-stage programs: bemdaneprocel (BRT-DA01) for Parkinson's disease and OpCT-001 for primary photoreceptor diseases affecting vision. With operations spanning Cambridge, Massachusetts; Toronto, Ontario; New York; and Berlin, BlueRock employs 201-500 professionals dedicated to advancing cell and gene therapies. The company's mission centers on harnessing the power of cell therapy to create breakthrough medicines for patients with limited treatment options, operating at the intersection of neurology, cardiology, and immunology research.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.